ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule
European Journal of Cancer
◽
10.1016/s0959-8049(99)81937-6
◽
1999
◽
Vol 35
◽
pp. S374
◽
Cited By ~ 1
Author(s):
K. Belanger
◽
R. Tozer
◽
S. Burdette-Radoux
◽
M. Davis
◽
R. Lohmann
◽
...
Keyword(s):
Malignant Melanoma
◽
Phase Ii
◽
Phase Ii Study
◽
Stopping Rule
◽
Randomized Phase Ii
Download Full-text
Related Documents
Cited By
References
Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: A randomized phase II study
Medical Oncology and Tumor Pharmacotherapy
◽
10.1007/bf02985163
◽
1989
◽
Vol 6
(4)
◽
pp. 285-289
◽
Cited By ~ 6
Author(s):
U. Ringborg
◽
C. -M. Rudenstam
◽
J. Hansson
◽
L. Hafström
◽
B. Stenstam
◽
...
Keyword(s):
Malignant Melanoma
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Efficacy, safety and predictive biomarker results from a randomized phase II study comparing atezolizumab vs. docetaxel in patients with advanced NSCLC (POPLAR)
Pneumologie
◽
10.1055/s-0036-1572212
◽
2016
◽
Vol 70
(S 01)
◽
Author(s):
A Rittmeyer
◽
A Spira
◽
K Park
◽
J Mazieres
◽
J Vansteenkiste
◽
...
Keyword(s):
Phase Ii
◽
Advanced Nsclc
◽
Phase Ii Study
◽
Predictive Biomarker
◽
Randomized Phase Ii
Download Full-text
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Case Medical Research
◽
10.31525/ct1-nct04095208
◽
2019
◽
Author(s):
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Proof Of Concept
◽
Randomized Phase Ii
◽
Metastatic Soft Tissue Sarcoma
Download Full-text
Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Multiple Myeloma.
Case Medical Research
◽
10.31525/ct1-nct04277845
◽
2020
◽
Author(s):
Keyword(s):
Multiple Myeloma
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Faculty Opinions recommendation of Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717962446.793468191
◽
2012
◽
Author(s):
Steven Le Gouill
◽
Cyrille Touzeau
Keyword(s):
Multiple Myeloma
◽
Phase Ii
◽
Induction Therapy
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Faculty of 1000 evaluation for Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718021759.793480257
◽
2013
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Progesterone Receptor
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Faculty of 1000 evaluation for A Double-Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-L-Carnitine in the Prevention of Sagopilone-Induced Peripheral Neuropathy.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718136956.793486581
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Peripheral Neuropathy
◽
Phase Ii
◽
Phase Ii Study
◽
Double Blind
◽
Safety And Efficacy
◽
Randomized Phase Ii
Download Full-text
Faculty Opinions recommendation of Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.734565867.793581155
◽
2020
◽
Author(s):
David Potter
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Neoadjuvant Therapy
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Estrogen Receptor Positive
Download Full-text
Randomized Phase II Study of CPT-11 vs PTX; +/- S1 in Advanced Gastric Cancer Refractory to S1 or S1 + Platinum
Annals of Oncology
◽
10.1093/annonc/mdu165.44
◽
2014
◽
Vol 25
◽
pp. ii28
Author(s):
Goto Masahiro
◽
Imamura Hiroshi
◽
Kawase Tomono
◽
Kimura Yutaka
◽
Ueda Shugo
◽
...
Keyword(s):
Gastric Cancer
◽
Advanced Gastric Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Randomized Phase Ii Study of S-1 Plus Oral Leucovorin (Sl) Versus Sl Plus Oxaliplatin (Sol) Versus S-1 Plus Cisplatin (Sp) in Patients with Advanced Gastric Cancer (Agc):Updated Overall Survival Data
Annals of Oncology
◽
10.1093/annonc/mdu334.10
◽
2014
◽
Vol 25
◽
pp. iv213
◽
Cited By ~ 1
Author(s):
K. Yamaguchi
◽
S. Hironaka
◽
N. Sugimoto
◽
T. Moriwaki
◽
Y. Komatsu
◽
...
Keyword(s):
Gastric Cancer
◽
Overall Survival
◽
Advanced Gastric Cancer
◽
Phase Ii
◽
Survival Data
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close